"O Centro Multidisciplinar de Estudos Clínicos – CEMEC se destaca no cenário global da pesquisa clínica como um centro munido de conhecimento, experiência, que preza a segurança e qualidade na condução de estudos clínicos."

During the past decade, CEMEC - Centro Multidisciplinar de Estudos Clínicos conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 7 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 7 clinical trials were completed. i.e. 25.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Vaccines & Prevention B.V." with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" are "Crohn's Disease" (4 trials), "COVID-19" (3 trials), "Depressive Disorder, Major" (3 trials), "Heart Failure" (2 trials) and "Schizophrenia" (2 trials). Many other conditions were trialed in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" in a lesser frequency.

Most popular intervention types in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" are "Drug" (31 trials), "Biological" (6 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Empagliflozin" (4 trials), "Esketamine" (2 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "CEMEC - Centro Multidisciplinar de Estudos Clínicos" are 34 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CEMEC - Centro Multidisciplinar de Estudos Clínicos". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CEMEC - Centro Multidisciplinar de Estudos Clínicos, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in CEMEC - Centro Multidisciplinar de Estudos Clínicos, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".